Antimicrobial susceptibility of group B streptococci.
D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology; D002939:Ciprofloxacin; D005260:Female; D006801:Humans; D015378:Imipenem; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D013292:Streptococcus agalactiae / Q000187:drug effects*; D013845:Thienamycins / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D011804:Quinolines; D013845:Thienamycins; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D015378:Imipenem; D014295:Trimethoprim